Back to top
more

Cardinal Health (CAH)

(Delayed Data from NYSE)

$94.10 USD

94.10
1,891,045

-0.36 (-0.38%)

Updated Jul 12, 2024 03:59 PM ET

After-Market: $94.12 +0.02 (0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (77 out of 250)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Glaukos (GKOS) Gains Nearly 25% YTD: What's Driving the Rally?

Glaukos' (GKOS) shares have risen year to date on the back of strong fundamentals. However, rising costs can be a cause of concern.

Labcorp's (LH) At-Home Mpox Testing Kit Gets the FDA's EUA Nod

Labcorp (LH) receives the FDA's Emergency Use Authorization for the Mpox PCR Test Home Collection Kit.

Why You Should Add Haemonetics (HAE) to Your Portfolio Now

Recovery within the Hospital business and the favorable prospects of the Plasma franchise raise investors' optimism for Haemonetics (HAE).

Cardinal Health, Inc. (CAH) is Attracting Investor Attention: Here is What You Should Know

Cardinal (CAH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Comfort Systems USA and Boeing have been highlighted as Zacks Bull and Bear of the Day

Comfort Systems USA and Boeing are part of the Zacks Bull and Bear of the Day article.

Indrajit Bandyopadhyay headshot

3 Medical Device Stocks With Solid Dividend Yield: CAH & Others

Here we discuss three medical device stocks, Cardinal Health (CAH), Baxter International (BAX) and Fresenius Medical Care (FMS), with a solid five-year dividend growth history.

Here's Why You Should Add DaVita (DVA) to Your Portfolio

DaVita's (DVA) strength in its kidney care raises optimism about the stock.

Integer Holdings (ITGR) Hits 52-Week High: What's Driving It?

Investors are optimistic about Integer Holdings' (ITGR) research and product development activities.

Reasons to Hold Baxter International (BAX) in Your Portfolio

Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, raises optimism.

Align Technology (ALGN) Up 20.5% YTD: Will the Rally Continue?

Investors are optimistic about Align Technology (ALGN) driven by geographic expansion and upbeat guidance.

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now

Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.

Here's Why You Should Retain Merit Medical (MMSI) Stock for Now

Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.

Boston Scientific (BSX) Faces Rising Costs, Competition

With Boston Scientific (BSX) recording 40% of its sales from the international market, it remains highly exposed to currency fluctuations.

Neogen (NEOG) Q3 Earnings Miss Estimates, Gross Margin Expands

Neogen's (NEOG) third-quarter fiscal 2024 results reflect solid core revenue growth in both segments.

Why You Should Retain Integer Holdings (ITGR) Stock for Now

Integer Holdings' (ITGR) research and product development activities raise optimism about the stock.

Why You Should Retain Inari Medical (NARI) Stock for Now

Inari Medical (NARI) continues to gain from its expanded product portfolio. However, continued loss at the operating level raises concern.

Shockwave Medical's (SWAV) Reducer Receives Positive Results

Shockwave Medical (SWAV) announces the 'real-world' results of the REDUCER-I study, which is intended to collect long-term outcomes on Shockwave Reducer, a novel treatment for refractory angina.

Do Options Traders Know Something About Cardinal Health (CAH) Stock We Don't?

Investors need to pay close attention to Cardinal Health (CAH) stock based on the movements in the options market lately.

Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now

Investors are optimistic about Myriad Genetics' (MYGN) strong solvency position and improvement in testing volume.

Labcorp's (LH) Strategic Alliances Aid Amid Macroeconomic Woes

Labcorp (LH) is investing in innovation and technology that supports diagnostic and drug development testing for various diseases such as cancer and Alzheimer's.

Bruker (BRKR) Introduces Magnet Technology for NMR Adoption

Bruker's (BRKR) latest novel technology facilitates the widespread application of NMR in academic basic and clinical research.

Here's Why Investors Should Retain Integra (IART) Stock Now

Integra's (IART) strong focus on portfolio optimization and international expansion bolsters investors' confidence in the stock.

Thermo Fisher (TMO) Launches TSX Universal Series ULT Freezers

Thermo Fisher's (TMO) new ENERGY STAR-certified TSX Universal Series ULT Freezers deliver tighter temperature control and faster recovery times.

Is JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) a Strong ETF Right Now?

Smart Beta ETF report for JPME